Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)

US National Institutes of Health (NIH) grant open #PAR-25-221

Response due Jan 07, 2027 · 00:00 UTC

Summary

This NIH funding opportunity (PAR-25-221) solicits R01 research grant applications focused on population-level approaches to reducing alcohol-related cancer risk. Clinical trials are optional under this mechanism. The opportunity is issued by the National Institutes of Health under the Department of Health and Human Services. The solicitation opened in November 2024 and accepts applications through January 2027, suggesting multiple submission cycles.

How they evaluate

Submission: Grants.gov federal grants portal (electronic submission)

Risks & flags

No dollar value or award ceiling stated — budget scope unclear
Multi-year open window (Nov 2024 – Jan 2027) with likely multiple receipt dates not specified in this synopsis

Market context

inferred from NAICS

R&D in Physical, Engineering, Life Sciences (except Nanotech & Biotech)

NAICS 541715

US market size: $95B
Typical award: $100K – $50M+

Typical buyers

DoDNSFNIHNASADOE

Commonly required

DCAA-compliant accountingITARCMMC L2

Population Approaches to Reducing Alcohol-…

Due Jan 07

Onboard ↗